Navigation Links
Lead testing in children of Mt Isa

Queensland Health will start the blood testing in children of Mt Isa today to determine the level of lead absorbed, due to the concerns over emissions from Xstrata's two Mount Isa smelters.//

In June, Queensland's Environmental Protection Agency raised concerns about the need for health checks in children of Mt Isa. Blood sample will be collected from 400 children aged 1-4.

John Piispanen from the Tropical Population Health Unit says, "The testing is precautionary because of Mount Isa's mining industry and its location in a mineralised area. We need to find out what we'd consider a background level in the population to see whether that's a risk to the population."

Parents’ consent will be got by the officials at hospital and childcare centres for children to participate in the testing. "Children aged one to four are more sensitive indicators of environmental lead contamination so we've targeted those," he said.

Under World Health Organisation (WHO) standards, less than 10 micrograms per deciliter of blood-lead level is considered harmless.
"Children with lead levels at or more than that will be seen by their family doctor, a pediatrician or the TPHU, " Mr Piispanen said. "An environmental health officer will also offer an environmental audit to determine where the child was exposed to lead and to minimise future risks, " he added.

High levels of lead were observed in one-third of the city’s children when the test was done 12 years ago.
GY
'"/>




Page: 1

Related medicine news :

1. Diabetic testing gets easier
2. FDA changes rules on testing drugs for children
3. Gene testing kit specific for Doctors
4. H.Pylori testing recommended in patients with peptic ulcer
5. Eye testing can reveal the condition of your heart
6. Compulsory testing for heavy metal content in herbal medicines
7. Urine testing for telomerase enzyme for bladder cancer diagnosis
8. AIDS testing gets support from Bill Clinton
9. HIV /AIDS testing center at Malawis parliament.
10. Bird-Flu Vaccine to go for second round of testing on humans
11. Novel Test Promises to Save Babies from ‘testing’ Tims
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: